Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
ACR Open Rheumatology|November 2, 2023
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic SurveyGerlando Natalello, Silvia Laura Bosello, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)|February 17, 2026
Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing frameworkSilvia Laura Bosello, Augusta Ortolan, Lucia Lanzo, et al.
Rheumatology (Oxford, England)|January 29, 2020
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysisGiacomo De Luca, Corrado Campochiaro, Maria De Santis, et al.
Microvascular Research|September 19, 2020
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvementGerlando Natalello, Giacomo De Luca, Laura Gigante, et al.
Rheumatology (Oxford, England)|June 16, 2022
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung diseaseCosimo Bruni, Mariaelena Occhipinti, Michael Pienn, et al.
RMD Open|February 22, 2023
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria-Grazia Lazzaroni, et al.
Rheumatology (Oxford, England)|May 15, 2024
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre studyGiacomo De Luca, Enrico De Lorenzis, Corrado Campochiaro, et al.
Clinical and Experimental Medicine|April 17, 2019
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT studySimone Negrini, Ottavia Magnani, Marco Matucci-Cerinic, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Rheumatology (Oxford, England)|September 30, 2024
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-lifeEnrico De Lorenzis, Gerlando Natalello, Greta Pellegrino, et al.
Pageof 6